VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
GDRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
GDRXGoodRx Holdings, Inc.
$3.28$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGDRXEarnings History

GDRX logoGoodRx Holdings, Inc. (GDRX) Earnings History

Profitable

8 years of earnings data (2018–2025) · Positive TTM net income

TTM Net Income
$16M
● Profitable
TTM EPS (Diluted)
$0.05
Per share, diluted
YoY EPS Growth
+104.1%
Excellent
Net Margin
3.8%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+104.1%
3YN/A
5YN/A
10YN/A
Operating Margin11.0%
Gross Margin92.8%
Return on Equity4.5%
Return on Assets2.2%
Record Annual Net Income$66MFY2019
Record Quarterly EPS$0.14Q2 2023
Consecutive Profitable Years2years
Q2 2026
Net Income$9M
EPS (Diluted)$0.02
YoY Growth+104.1%Excellent
QoQ Growth+630.2%Excellent

Loading earnings history...

GoodRx Holdings, Inc. (GDRX) Earnings Overview

As of October 3, 2026, GoodRx Holdings, Inc. (GDRX) reported trailing twelve-month net income of $16M, reflecting +104.1% year-over-year growth. The company earned $0.05 per diluted share over the past four quarters, with a net profit margin of 3.8%.

Looking at the long-term picture, GDRX's historical earnings data spans multiple years. The company achieved its highest annual net income of $66M in fiscal 2019.

GoodRx Holdings, Inc. maintains positive profitability with a gross margin of 92.8%, operating margin of 11.0%, and net margin of 3.8%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including HIMS (-$142M net income, 5.5% margin), TDOC (-$177M net income, -7.9% margin), OPRX ($5M net income, 4.7% margin), GDRX has room to improve margins relative to the peer group. Compare GDRX vs HIMS →

GDRX Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
GDRX logoGDRXCurrent
$16M$0.053.8%4.5%+104.1%—
HIMS logoHIMS
-$142M$-0.615.5%25.2%-3.8%
TDOC logoTDOC
-$177M$-0.99-7.9%-13.9%+80.6%
OPRX logoOPRX
$5M$0.244.7%4.2%+124.5%
PHVS logoPHVS
-$172M$-2.52--65.2%-19.8%
DOCS logoDOCS
$167M$0.8730.4%19.3%-11.7%
Best in group
Lowest in group

GDRX Historical Earnings Data (2018–2025)

8 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$30M+85.7%$87M$0.093.8%11.0%
2024$16M+284.8%$66M$0.042.1%8.3%
2023-$9M+73.0%-$27M$-0.02-1.2%-3.6%
2022-$33M-30.0%$2M$-0.08-4.3%0.2%
2021-$25M+91.4%$13M$-0.06-3.4%1.8%
2020-$294M-544.6%-$276M$-1.07-53.3%-50.1%
2019$66M+50.8%$140M$0.1217.0%36.0%
2018$44M-$77M$0.1217.6%31.0%

Download Data

Export GDRX earnings history in CSV or JSON format

Free sign-in required to download data

Consensus & Technical Research Suite
Open GDRX Terminal

GDRX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GDRX — Frequently Asked Questions

Quick answers to the most common questions about buying GDRX stock.

What is GDRX earnings per share (EPS)?

GDRX trailing twelve-month (TTM) diluted EPS is $0.05, reflecting +104.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.

What is GoodRx Holdings, Inc.'s net income?

GoodRx Holdings, Inc. (GDRX) trailing twelve-month net income is $16M as of 2025. Earnings grew +104.1% year-over-year. GoodRx Holdings, Inc. has been profitable for 2 consecutive years.

Is GDRX profitable?

Yes, GDRX is profitable with a TTM net income of $16M and a net profit margin of +3.8%. GoodRx Holdings, Inc. has generated profits for 2 consecutive years.

What is GDRX's earnings growth rate?

GDRX compound annual EPS growth rates (CAGR): 1-Year: +104.1%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.

What are GDRX's profit margins?

GoodRx Holdings, Inc. net profit margin is +3.8%, operating margin is +11.0%, and gross margin is +92.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.5%.

Is GDRX growing earnings?

Yes, GDRX earnings are accelerating — EPS growth of +104.1% exceeds the 5-year CAGR of N/A. TTM net income reached $16M. Earnings momentum is strengthening.

What was GDRX's best earnings year?

GoodRx Holdings, Inc.'s highest annual net income on record is $66M, achieved in fiscal year 2019. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.

What were GDRX's earnings last quarter?

GDRX's most recent reported quarter was Q2 2026. Net income was $9M with diluted EPS of $0.02. For a full breakdown of all quarters, see the quarterly earnings table on this page.

GDRX Earnings Over Time (2018–2025)

Net income & EPS — annual and quarterly view